NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1669442638 M.D.
Verify on CMS → Mounzer Agha, M.D.
Hematology & Oncology Physician in Pittsburgh, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 193 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
61%
generic claims · 38% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · Above neutral
Industry payments
$134.68
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Mounzer Agha, M.D. reported a CMS MIPS final score of 75/100 - below the 83.1 national average - and filed 1,664 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 2K
- Part D claims, 2023
- 61%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Mounzer Agha, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mounzer Agha, M.D. sits
This provider among hematology & oncology physician peers
Across the 4,233 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mounzer Agha, M.D. writes more Part D claims than 84% of them and scores higher on MIPS quality than 13% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Mounzer Agha, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Mounzer Agha, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mounzer Agha, M.D.?
Below national averagePrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
1,664 96% vs specialty avg
MIPS final score
75/100 8.1 pts vs avg
Specialty distribution in Pennsylvania
How Hematology & Oncology Physician compares to other specialties among Pennsylvania providers
Medicare quality performance, MIPS
Mounzer Agha, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Hematology & Oncology Physician) - 75/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Mounzer Agha, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 5115 CENTRE AVE, Pittsburgh, PA, 15232, with a listed phone of (412) 235-1020. NPI 1669442638 was issued on 01/24/2006.
Medicare Part D records for calendar year 2023 show 1,664 prescription claims written by this provider, covering 193 Medicare beneficiaries and totaling roughly $7.1 million in drug spend, split 38% brand-name and 61% generic by claim count, with an opioid prescribing rate of 1.7%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1669442638 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 01/24/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
Avg: 83.1
Reporting: Group practice
Hospital and facility affiliations
Facilities where Mounzer Agha, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Oncology Hematology Association Inc
Pittsburgh, PA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mounzer Agha, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$135
Largest payer
Genmab U.S., Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Mounzer Agha, M.D.. To verify Mounzer Agha, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Mounzer Agha, M.D. - brand share 38.0%
Hematology & Oncology Physician average
38% brand-name claims vs 61% generic, on 1,664 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,664
Total Claims
$7.1M
Total Drug Cost
193
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,134
- Total Day Supply
- 58,179
- Brand vs Generic
- 38% brand / 61% generic
- Brand Drug Cost
- $6.5M
- Generic Drug Cost
- $657K
- Opioid Claims
- 29 (1.7% rate)
- Antibiotic Claims
- 146
Patient Demographics
- Average Patient Age
- 73.1 years
- Avg HCC Risk Score
- 3.01
- Gender Split
- 51% female / 49% male
- Age Distribution
- <65: 19, 65-74: 83, 75-84: 79, 85+: 12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mounzer Agha, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Acyclovir
Acyclovir
214 claims
- Venclexta
Venclexta
123 claims
- Imbruvica 69
Imbruvica
69 claims
- Calquence 64
Calquence
64 claims
- Sulfamethoxazole-T… 64
Sulfamethoxazole-Trimethoprim
64 claims
- Pomalyst 57
Pomalyst
57 claims
- Dexamethasone 53
Dexamethasone
53 claims
- Fluconazole 51
Fluconazole
51 claims
| Drug | Claims |
|---|---|
| Acyclovir | 214 |
| Venclexta Venetoclax | 123 |
| Imbruvica Ibrutinib | 69 |
| Calquence Acalabrutinib Maleate | 64 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 64 |
| Pomalyst Pomalidomide | 57 |
| Dexamethasone | 53 |
| Fluconazole | 51 |
| Pantoprazole Sodium | 50 |
| Lenalidomide | 45 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Mounzer Agha, M.D. fits within the Hematology & Oncology Physician landscape nationally.
11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Mounzer Agha, M.D.'s 1,664 claims are above the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Agha.
Dr. Abdullateef Abdulkareem
M.D.
Lancaster, PA
Dr. Charles Abrams
MD
Philadelphia, PA
Tala Achkar
Pittsburgh, PA
Dr. Monica Adedeji
MD, MPH
Hershey, PA
Dr. Giridhar Adiga
MD
Ephrata, PA
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Pennsylvania medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Pennsylvania
Frequently Asked Questions
What is Mounzer Agha, M.D.'s specialty? ▼
Mounzer Agha, M.D. specializes in Hematology & Oncology Physician and practices in Pittsburgh, Pennsylvania. Credentials: M.D..
How much does Mounzer Agha, M.D. prescribe under Medicare Part D? ▼
In 2023, Mounzer Agha, M.D. wrote 1,664 Medicare Part D claims totaling $7.1M in drug costs for 193 beneficiaries.
What is Mounzer Agha, M.D.'s Medicare quality score? ▼
Mounzer Agha, M.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mounzer Agha, M.D. located? ▼
Mounzer Agha, M.D. is located at 5115 CENTRE AVE, Pittsburgh, PA, 15232. Phone: (412) 235-1020.
What is Mounzer Agha, M.D.'s NPI number? ▼
Mounzer Agha, M.D.'s National Provider Identifier (NPI) is 1669442638, issued on 01/24/2006.
Does Mounzer Agha, M.D. prescribe more brand-name or generic drugs? ▼
Mounzer Agha, M.D.'s prescribing is 38% brand-name and 61% generic drugs by claim count, with $6.5M in brand drug costs.
Does Mounzer Agha, M.D. prescribe opioids? ▼
Yes, Mounzer Agha, M.D. had 29 opioid claims in 2023 with an opioid prescribing rate of 1.7%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Mounzer Agha, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Mounzer Agha, M.D.'s most frequently prescribed drugs include Acyclovir, Venclexta, Imbruvica. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mounzer Agha, M.D. accept Medicare? ▼
Mounzer Agha, M.D. appears in CMS Medicare data with 1,664 Part D claims and 193 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mounzer Agha, M.D.'s credentials? ▼
Mounzer Agha, M.D.'s NPI is 1669442638 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.